TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Expression of angiogenic markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of Pneumococcal Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity and specificity of C-Scan Capsule System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: technical skills in conducting VAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving at Least 1:4 rLP2086-specific Serum Bactericidal Assay (SBA) Titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Subjects Achieving PASI 75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Total number of subjects diagnosed with MS
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with investigational product-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Benefit Questionnaire (PBQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to exceed AG burden cut-off of 1%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boston Carpal Tunnel Questionnaire (BCTQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peak latency of the median sensory nerve action potential (SNAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of preoperative neck and radicular pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of motor power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Markers of DNA damage and oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of left atrial scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: prevalence of non-pulmonary vein triggers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: proportion of participants with HBV DNA < 20 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant smoking status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in acute metabolic and hormonal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in fat content of skeletal muscle and liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Eating Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: morbimortality
Endpoint domain: Mortality/survival
Primary endpoint: adverse events tracing
Endpoint domain: Adverse events/effects
Primary endpoint: Complete early virologic response (cEVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Relative amount of miR-1, miR-10b, miR-22, miR-92 and miR-192 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute deterioration of bronchiectasis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: vascular calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Post-bronchodilator FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence of profound perioperative anemia (Hb < 70 g/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: nadir perioperative Hb concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Net clinical benefit
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hamilton Depression Scale (HAM-D 17)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUCnic 0-240
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in C. difficile loads
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Long-term persistence of C. difficile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Lower Limb Physical Functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lower Limb Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of Patients With an Initial Therapeutic Anti-Xa Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Organ dysfunctions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative interrectus distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with 180-day new vascular events (stroke)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Time of peritonitis detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Score of the Quality of Recovery-40 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of caries adjacent to the restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Confirmed Anti-tumor Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: renal resistive index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bioavailability of the drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal concentration of the drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in ketone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Seroconversion rate for HI antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroprotection rate post-vaccination for HI antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in the Investigator Global Assessment (IGA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Contrast opacification of the target vascular segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Proportion of patients willing to undertake cardiac rehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Non-urgent ED visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of CD Participants Who Have CPAF
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean Costs for Crohn's Disease Participants With and Without CPAF
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Visits for Healthcare Resource Utilization for Crohn's Disease Participants With and Without CPAF
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intra-Ocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working Memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Processing Speed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Verbal learning and memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ANAM (Automated Psychological Assessment Metrics)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tumor response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Patients With Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Number of Days of Constipation or Diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage uptake of PPIUD
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Appearance of surgical scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in status of bone healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Blistering
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Difference of period length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % change in Lumbar Spine BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive capacity of changes in PPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of the analyte in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of the analyte in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing Function Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change in Glycosylated Hemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Immunogenicity of IMOVAX Polio™ vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety (local and systemic reactogenicity)
Endpoint domain: Adverse events/effects
Primary endpoint: Laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of sentinel node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of major, clinically important non-major or minor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Measure of Improvement Over the Standard
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Concordance of continuous glucose monitor with standard blood glucose measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in CAPS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Erosion Resistance (RER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surface Microhardness (SMH) Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive function in decompensated heart failure patients
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: cognitive function before and after medical recompensation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: differences in cognitive performance between groups
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Side effect symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Venous Thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of patients readmitted to the hospital within 30 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Levels of specific biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache Impact Test score change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants With DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Progression-free Survival (PFS-6) at Six Months
Endpoint domain: Mortality/survival
Primary endpoint: Hemoglobin concentration at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Extended rapid virologic response (eRVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-week sustained virologic response (SVR24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety measured by frequency of SAEs and discontinuations due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: maximum change in serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of Sleep Disordered Breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mu Suppression on EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pupil Dilation While Observing Faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of hip fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Clinical failure within 10 days of enrolment
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Subjects Reporting Rare Serious Events
Endpoint domain: Adverse events/effects
Primary endpoint: Confirmed response (PSA decline >50%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Radiomorphometric indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Severity Index (GSI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CD34+ collection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sensitivity and specificity of biopsies for adenomyotic tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Gingival Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Esthetic Appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bioequivalence Based on Rmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence Based on Ae0-36
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIBP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biliary access for therapy achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: persistent retained pregnancy products rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Narcotic Utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Patients Achieving a Palmar/Plantar PGA Score of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in rumination frequency in daily life
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in the impact of daily rumination on daily mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Success rate of epidural anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Correlation between difficult airway indicators and cricothyroid membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural tube defects incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of intrusive memories
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of SDB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Consumed quantity of ONS in weight percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life of family members
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change From Baseline in Peak Eosinophil Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Serious and Grade 3 or Higher Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Bleb vascular change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Post-Traumatic Stress Disorder Checklist-Military Version (PCL-M)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MSSA/MRSA prevalence in a general ED-population
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MSSA/MRSA in-hospital infection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean Change in Eczema Area and Severity Index (EASI) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RettBE 1.0 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RettBe 2.0 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RettBe 3.0 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse-free survival time
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of white-coat hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of diurnal hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of 24-hour hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum Creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Creatinine clearance according to Cockroft-Gault equation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Thickness of the silicone layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LH levels in response to estrogen negative feedback
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: LH levels in response to estrogen positive feedback
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Drinks Per Drinking Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of GSSS induced pH drop below 4.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall and sub domains scores for each questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to withdrawal
Endpoint domain: Mortality/survival
Primary endpoint: Women's experiences of supportive and dignified maternity care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lens Fit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distant metastasis free survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in Antihypertensive Medication Adherence using Pharmacy Records
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Antihypertensive Medication Adherence using Self-Reported Adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Antihypertensive Medication Adherence using Pill Counts
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prognostic prediction model for pulmonary contusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Contrast induced nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cmax,ss (After Multiple Dosing)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(Tau,ss) (After Multiple Dosing)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of infection with C.trachomatis, N. gonorrhea and Seroprevalence of HSV 2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Decline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of Decline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to first death
Endpoint domain: Mortality/survival
Primary endpoint: Time to graft failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to serious adverse event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Minutes of MVPA per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fruit and Vegetable Consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistence of Humoral Immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes